82 related articles for article (PubMed ID: 25910294)
1. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Li K; He WH; Fan NJ; Gao CF; Zhao G; Sun GB; Zheng GB
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():147-52. PubMed ID: 25910294
[TBL] [Abstract][Full Text] [Related]
2. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
[TBL] [Abstract][Full Text] [Related]
3. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
[TBL] [Abstract][Full Text] [Related]
4. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
[TBL] [Abstract][Full Text] [Related]
5. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
[TBL] [Abstract][Full Text] [Related]
6. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
[TBL] [Abstract][Full Text] [Related]
7. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
[TBL] [Abstract][Full Text] [Related]
8. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
9. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
Hu Q; Huang Y; Wang Z; Tao H; Liu J; Yan L; Wang K
Hepatogastroenterology; 2012 Sep; 59(118):1902-6. PubMed ID: 22193438
[TBL] [Abstract][Full Text] [Related]
10. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
11. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
12. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
13. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
He J; Zeng ZC; Xiang ZL; Yang P
World J Gastroenterol; 2014 Mar; 20(11):3025-32. PubMed ID: 24659894
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.
Zeng J; Yin P; Tan Y; Dong L; Hu C; Huang Q; Lu X; Wang H; Xu G
J Proteome Res; 2014 Jul; 13(7):3420-31. PubMed ID: 24853826
[TBL] [Abstract][Full Text] [Related]
16. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.
Kanmura S; Uto H; Kusumoto K; Ishida Y; Hasuike S; Nagata K; Hayashi K; Ido A; Stuver SO; Tsubouchi H
Hepatology; 2007 Apr; 45(4):948-56. PubMed ID: 17393466
[TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
18. Serum peptidome profiling for identifying pathological patterns in patients with primary nephrotic syndrome.
Huang LT; Wen Q; Zhao MZ; Li ZB; Luo N; Wang YT; Dong XQ; Yu XQ
Chin Med J (Engl); 2012 Dec; 125(24):4418-23. PubMed ID: 23253712
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu T; Xue R; Huang X; Zhang D; Dong L; Wu H; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):542-50. PubMed ID: 21659380
[TBL] [Abstract][Full Text] [Related]
20. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
Liu C; Shen J; Pan C; Yang L; Mou S; Wang H; Liang Y
Am J Clin Pathol; 2010 Aug; 134(2):235-41. PubMed ID: 20660326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
